Magnetic Resonance Angiography (MRA) Market Share and Competitive Landscape

Comments · 109 Views

The Magnetic Resonance Angiography (MRA) Market size was USD 2.89 Billion in 2022 and is projected to reach USD 4.48 Billion in 2032, with a forecasted revenue CAGR of 5%.

The Magnetic Resonance Angiography (MRA) Market size was USD 2.89 Billion in 2022 and is projected to reach USD 4.48 Billion in 2032, with a forecasted revenue CAGR of 5%. MRA is a non-invasive diagnostic imaging technology that employs Magnetic Resonance Imaging (MRI) to create detailed images of blood arteries. The prevalence of cardiovascular disorders is increasing globally, and advancements in imaging technology are driving the growth of the market. The aging population is another key factor driving market growth, as the incidence of cardiovascular disorders is expected to rise with the world's aging population. In addition, manufacturers are introducing new and improved MRI equipment to provide high-quality images with faster scan times and increased patient comfort, which is driving the need for MRA procedures. Clinical studies utilizing MRA techniques are also expanding, with researchers examining how environmental, lifestyle, and genetic factors contribute to cardiovascular disorders, and evaluating the efficacy of novel treatments and medications for these conditions.

However, the high cost of MRA procedures, the scarcity of skilled practitioners, and the absence of reimbursement policies in certain regions are impeding market revenue growth. The high cost of MRA treatments and a lack of qualified practitioners are constraining the adoption of MRA in low-income nations. Furthermore, the absence of reimbursement policies in some regions is hampering the development of the magnetic resonance angiography market.

Request a sample Report of  Magnetic Resonance Angiography (MRA) Market  @https://www.reportsanddata.com/download-free-sample/6248

Major Companies and Competitive Landscape:

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Bayer AG
  • Toshiba Corporation
  • Bracco Imaging S.p.A.
  • Fujifilm Holdings Corporation
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • Canon Medical Systems Corporation

Driving Factors in the Magnetic Resonance Angiography (MRA) Market are:

  1. Rising incidence of cardiovascular disorders: The increasing prevalence of cardiovascular disorders, such as stroke and coronary artery disease, worldwide is one of the major factors driving market revenue growth. MRA is essential in the diagnosis of cardiovascular disorders as it offers a thorough image of blood vessels and aids in locating any blockages or artery narrowing.
  2. Increasing global aging population: The prevalence of cardiovascular illnesses is expected to rise as the world's population continues to age, increasing the need for MRA operations. The United Nations predicts that by 2050, there will be over 2.1 billion people worldwide who are 60 years of age or older.
  3. Developments in imaging technology: Manufacturers are creating new and improved MRI equipment to provide high-resolution images with quicker scan times and increased patient comfort. These advancements in imaging technology are driving the demand for MRA procedures.
  4. Expansion of MRA techniques in research and clinical investigations: The use of MRA techniques in research and clinical investigations is expanding, driving market revenue growth. MRA is utilized in research studies to assess the effectiveness of novel treatments and medications for cardiovascular illnesses.

Despite these driving factors, the high costs of MRA procedures, scarcity of qualified practitioners, and absence of reimbursement policies in some areas hinder market revenue growth.

Request latest Report Insights of  Magnetic Resonance Angiography (MRA) Market  @https://www.reportsanddata.com/request-latest-insight/6248

Restraint in the Magnetic Resonance Angiography (MRA) Market:

The magnetic resonance angiography market is facing some constraints that hinder revenue growth. One of the main restraints is the high cost of MRA procedures, which makes it challenging for patients to access the technology. In addition, the scarcity of qualified practitioners who can operate the equipment is another significant constraint. This is particularly problematic in poorer countries, where access to medical resources is limited. Furthermore, the absence of reimbursement policies in some areas is hindering the development of the magnetic resonance angiography market. As a result, patients may not be able to afford the cost of MRA procedures, which could limit their access to this important diagnostic tool.

Notable Innovations in the Magnetic Resonance Angiography (MRA) Market are:

  1. Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA): This is a technique that uses a contrast agent to enhance the visibility of blood vessels and improve the accuracy of MRA images.
  2. Time-of-Flight (TOF) MRA: This is a technique that uses the flow of blood to create images of blood vessels. It is a non-invasive and high-resolution imaging method that can be used to visualize blood flow through arteries and veins.
  3. 4D MRA: This technique involves the use of high-speed MRI scanning to capture images of blood flow through arteries and veins in real-time. It provides a 3D representation of blood vessels and shows how blood flows through them over time.
  4. High-resolution MRA: This is a technique that uses high-field MRI scanners to capture detailed images of blood vessels with greater clarity and accuracy.
  5. Magnetic Resonance Venography (MRV): This is a technique that uses MRI to create images of the veins in the body. It is commonly used to diagnose conditions such as deep vein thrombosis.
  6. Ultrasmall Superparamagnetic Iron Oxide (USPIO) MRA: This is a technique that uses contrast agents made up of tiny iron particles to enhance the visibility of blood vessels in MRA images.
  7. Time-Resolved MRA (TR-MRA): This is a technique that uses rapid imaging sequences to capture images of blood flow through arteries and veins in real-time. It provides a 3D representation of blood vessels and shows how blood flows through them over time.

Request a Report Customization of  Magnetic Resonance Angiography (MRA) Market   @https://www.reportsanddata.com/request-customization-form/6248

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs

https://portalaz.com.br/client_login_check?redirectUrl=https://www.reportsanddata.com

https://izispicy.com/go.php?url=https://www.reportsanddata.com

https://www3.valueline.com/vlac/logon.aspx?lp=https://www.reportsanddata.com

https://www.videoder.com/af/media?mode=2url=https://www.reportsanddata.com

https://drugs.ie/?URL=https://www.reportsanddata.com

Comments